Redcliffe Labs appoints Abhay Singavi as Chief Business Officer (CBO)

Takes charge to lead business innovation, strategy, Alliance & Partnerships

7th Feb 2022, India: Redcliffe Labs, also known as Redcliffe Life Diagnostics (, has recently appointed Abhay Singavi as Chief Business Officer (CBO). In his role, Abhay Singavi will be responsible to executing the company’s business strategy, driving the overall growth and performance of key business units as a strategy, operations and business transformation lead

Abhay brings with himself an extensive experience of around 15 years. He has worked with Narayana Health as CEO leading the preventive health division of the company. Thereafter, Abhay worked as P&L Head in Medanta and Policy Bazaar. Abhay’s most recent stint was as CBO at Healthians. 

Commenting on Abhay’s induction, Dheeraj Jain, Founder, Redcliffe Labs, said, “We are elated to have Abhay onboard and towards building Redcliffe integrated to larger Healthcare ecosystem with his substantial experience and expertise in Healthcare. Under his able guidance, the team will work towards a directional approach in terms of planning and strategizing operations to achieve our aim of making diagnostics accessible to everyone.”

Adding to this, Abhay Singavi, said, “Having worked closely with various companies in the healthcare sector, I have seen how a far sighted business approach leads to the success of an organization. In my new role at Redcliffe Labs, my efforts will be directed towards building strategic operations, partnerships and aligning strategies that work best towards the company’s business goals.” 

About Redcliffe Labs:

Redcliffe Labs provides diagnostics with a comprehensive portfolio approach both with routine and specialized test menus with advanced testing labs all over India. Its digital first approach with on-demand 1 hour home collection and same day report is disrupting the way diagnostics is delivered today and thus is the fastest growing in India. It aspires to be the best in terms of precision and personalization of testing.


*This press release is published by VOH team*

Partners & Associate